ClinicalTrials.govpublic full text
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
refractory follicular lymphoma, relapsed follicular lymphoma, ibrutinib, venetoclax, follicular, refractory, relapsed, lymphoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827412
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.